Systematic review of immunosuppressant guidelines in the COVID-19 pandemic.

ABSTRACT:

Aims

Individuals taking immunosuppressants are at increased susceptibility to viral infections in general. However, due to the novel nature of the COVID-19, there is a lack of evidence about the specific risks of the disease in this patient group. This systematic review aims to summarize the current international clinical guidelines to highlight areas where research is needed through critical appraisal of the evidence base of these guidelines.

Methods

We conducted a systematic review of clinical practice guidelines about the usage of immunosuppressants during the COVID-19 pandemic. Electronic databases including MEDLINE and the websites of relevant professional bodies were searched for English language guidelines that were published or updated between March 2020 and May 2020

SUBMITTER: Barlow-Pay F 

PROVIDER: S-EPMC7882764 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature